Details for Patent: 8,835,460

Which drugs does patent 8,835,460 protect, and when does it expire?

Patent 8,835,460 protects SUBSYS and is included in one NDA.

This patent has twenty-three patent family members in sixteen countries.

Summary for Patent: 8,835,460

Title:	Sublingual fentanyl spray and methods of treating pain
Abstract:	The present invention is directed to sublingual formulations containing fentanyl, a pharmaceutically acceptable salt thereof, or derivative thereof, suitable for administration to a patient, and methods for treatment with the formulations.
Inventor(s):	Kottayil; S. George (Long Grove, IL), Goskonda; Venkat R. (Phoenix, AZ), Zhu; Zhongyuan (Vernon Hills, IL), Kattookaran; Linet (Mount Prospect, IL), Parikh; Neha (Chicago, IL)
Assignee:	Insys Therapeutics, Inc. (Phoenix, AZ)
Application Number:	13/895,124
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 8,835,460
Patent Claim Types: see list of patent claims	Composition; Formulation; Compound; Device; Use;

Drugs Protected by US Patent 8,835,460

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-001	Jan 4, 2012		DISCN	Yes	No			Y			TREATMENT OF PAIN
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-002	Jan 4, 2012		DISCN	Yes	No			Y			TREATMENT OF PAIN
Btcp Pharma	SUBSYS	fentanyl	SPRAY;SUBLINGUAL	202788-003	Jan 4, 2012		DISCN	Yes	No			Y			TREATMENT OF PAIN

International Family Members for US Patent 8,835,460

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2007208229
Brazil	PI0707235
Canada	2637672